Awareness is growing of Multistem's potential, Crush. I've owned ATHX for a few years and started adding after the first stroke trial. It's interesting to see how curative Multistem is because the results take time and originally, nobody except ATHX realized in the first trial that Multistem treatment was effective. The proof came at 6 months in the trial arm that was administered 30 hrs after a stroke. This arm actually outperformed standard of care treatment. Stunning! At 1 year, the results were even far more outstanding and obvious for this arm. I expect this same result to be proven again, as nothing else has ever had this same effect on stroke patients. Here's what's likely to happen, based on past investment trends. The first six months it will be very quiet. Then an interim report will come out and Multistem patients will be slightly improved. Some biotech writers might notice this. At one year, Multistem patients will have a full/near complete recovery from stroke. Then the fireworks will start in earnest. To watch this stock day by day is to watch water come to a boil. But when the final results of the trial start to come out, ATHX will be a rocket. Especially if the FDA approval rumors start. My suggestion is to buy on the dips and hold, and ignore the daily gripes from the peanut gallery on message boards. From everything I've seen and read for the past two years, ATHX has a very bright future. But it takes a long time to run a stroke trial because there is no "instant" fix. In fact, there is little else than Multistem to help stroke victims, especially after the first four hours of the stroke which is the only time window for current treatments. After four hours, a stroke victim today has little hope and little to help them recover, except physical therapy. Multistem will be welcomed with open arms by health professionals and patients alike when it is approved in the US, EU and Japan. All three administrative bodies are coordinated because current trials are so important to patients who suffer from strokes.
